Category: Hepatitis C

Update on PHAC’s HIV and Hepatitis C Activities

Under the Federal Initiative to Address HIV/AIDS in Canada and the Hepatitis C Prevention, Support and Research Program, the Agency currently manages separate funding programs to support the community response to HIV and hepatitis C. The projects under these programs are in the process of being extended for three years, from April 1, 2014 –… Read more »

CATIE HepCinfo Update 5.5

6 week treatment cures almost all “hard to treat” participants A six-week treatment of sofosbuvir (Sovaldi), ledipasvir and a third drug cured a majority of people with genotype 1 Hep C virus who had never been treated before, according to research presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) in Boston…. Read more »

CATIE’s HepCInfo Update 5.4

New and Noteworthy European Medicines Agency advises on compassionate use of sofosbuvir (Sovaldi) and ledipasvir The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the compassionate use of sofosbuvir (Sovaldi) and ledipasvir for people with hepatitis C who are at high risk of liver failure or death within 12 months…. Read more »

Spring update from PHCN

This last month has been a whirlwind of symposiums, conferences and meetings.  We learned and shared a lot during our time spent with colleagues and collaborators across the country.  At the PAN ‘Effective Interventions’ conference in Vancouver, we presented on the benefits of the Community Readiness Model.   In Toronto, we presented about the patient experience… Read more »

CATIE’s HepCInfo Update 5.1

New and Noteworthy Montreal study shows testing positive for hepatitis C linked to decreased injection drug use People who inject drugs and who test positive for hepatitis C were more likely to decrease their drug use then people who tested negative, reported researchers in Clinical Infectious Diseases. From 2004 to 2011, the University of Montreal… Read more »

Dec 23, 2013 03:06 pm | Deb Schmitz   Recent comments by Liberal MP Gerry Byrne regarding Pamela Anderson show the depth of stigma and misinformation about hepatitis C that still exists in Canada today. President of Pacific Hepatitis C Network and hepatitis C survivor Daryl Luster states, “Stigma related to hepatitis C, and the… Read more »

February 26 – 28, 2014, Richmond, BC  Registration Deadline: Friday, January 24th @4:00pm The Pacific AIDS Network (PAN) is excited to announce that we will be hosting a two and a half day conference for PAN member organizations and other allied/partner organizations, where frontline prevention, education, harm reduction, health promotion workers and program managers and… Read more »